$GMRS

Van Horne Edward sold $3.2M of GMRS

Van Horne Edward (President & COO) sold 262,278 shares of GMR Solutions Inc. (GMRS) at $12.20 ($3.20M total) on 2026-09-14.

Original reporting
SEC EDGAR · Van Horne Edward
Published Sep 15, 2026, 10:06 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 10:16 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GMRS
Bearish
medium confidence
Mentioned
$GMRS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GMRSBearishLow
01

Why it matters

The disclosed sale reduces insider ownership, which may be interpreted as a negative signal by the market.

02

Market read

First report of a significant insider sell; modest trading relevance.

03

What to watch

No 10b5‑1 plan and the insider retains a sizable stake, indicating continued confidence.

Relevance 6/10Novelty 4/10Timing: post‑market 2026‑09‑14

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$GMRSBearishMedium confidence
Context

President & COO sold 262,278 shares for $3.2M, reducing his stake to 575,004 shares.

Expected impact

Potential modest downside pressure over the next few days.

Evidence & confidence

C‑level insider sale of $3.2M is material for a mid‑cap, suggesting possible concerns.

Market effects

Minimal; insider sell does not affect sector trends.

None; company is US‑based.

Low; limited to GMRS shareholders.

Counterpoint

The sale could be a routine diversification rather than a red flag.

Key entities

  • Van Horne Edward

    President & COO of GMR Solutions Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GMRSMed

GMR Solutions Inc. (GMRS): Results of Operations and Financial Condition

GMR Solutions Inc. (GMRS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ ​ GMR Solutions Inc. Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Reaffirms Full Year 2026 Guidance LEWISVILLE, Texas (August 12, 2026) — GMR Solutions Inc. (“GMR” or the “Company”) (NYSE: GMRS), the nation’s largest provider of em

$PBLSMed

Top Biotech Gainers: PBLS Soars Over 50%, CLOV Rallies On Legal Win, RNAZ, TMCI On Watch

Biotech stocks rose on varied catalysts. Parabilis (PBLS) debuted on Nasdaq, up 58% to $31.60 after pricing a $20.00 IPO of 33.5M shares for ~$670M gross proceeds. Clover Health (CLOV) gained 14% to $4.89 after a court ruling upgraded its 2026 PPO Star Rating to 4.5 from 3.5. Myomo (MYO) rose 17% to $1.54; Shoulder Innovations (SI) up 17% to $17.89; GMRS up 13% to $13.18.

$GMRSMedAI 9/10

Full Transcript: GMR Solutions Q1 2026 Earnings Call - GMR Solutions (NYSE:GMRS)

GMR Solutions (NYSE:GMRS) reported Q1 2026 revenue of $1.46 billion (+6.6% YoY) and adjusted EBITDA of $305 million (+9.7%). The company said its recent IPO leaves net leverage around 3.5x. It cited a 47% rise in 911 nurse navigation calls and nearly $47 million in incremental annualized revenue from new agreements. 2026 guidance targets $5.89–$6.18 billion revenue and high single-digit adjusted EBITDA growth.